(4aS,8aR,8bR,9aS,12S,12aS,13S,14aR,14bR)-12-(3-Furyl)-7,13-dihydroxy-6,6,8a,12a-tetramethyl-4,4a,8a,12,12a,13,14,14a-octahydro-3H-oxireno[d]pyrano[4',3':3,3a][2]benzofuro[5,4-f]isochromene-3,8,10(6H,9 aH)-trione(CAS: 120722-04-5)

This compound falls under the scope of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and requires proper labeling, storage, and handling. In the European Union, it is regulated under the REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) framework. FDA and EPA may have additional requirements related to its use in pharmaceuticals and environmental regulations.

There are several analogs and isomers that can be used as alternatives in synthesis, such as different furan-substituted isomers or related oxireno systems. Common alternative reagents might include various furan derivatives or other isocromene analogues.

Research trends suggest increasing interest in this compound for its potential use in pharmaceuticals and materials science. Market trends indicate growing demand, particularly in the development of novel drugs and high-performance polymers. The compound's unique structure may drive further exploration in these fields.

Waste containing this compound should be collected in appropriate containers and disposed of through incineration or professional waste disposal services. Environmental protection precautions should include ensuring no release into water bodies and adherence to local and national environmental regulations. Proper documentation and handling procedures are essential to comply with regulatory requirements.